Eagle Pharmaceuticals (EGRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 55,321 | 97,659 | 103,155 | 109,775 | 78,791 |
| Receivables | 72,439 | 41,149 | 51,117 | 48,004 | 66,486 |
| Inventories | 47,794 | 21,908 | 8,075 | 6,566 | 8,304 |
| TOTAL | $188,754 | $172,606 | $166,065 | $179,449 | $163,844 |
| Non-Current Assets | |||||
| PPE Net | 1,168 | 1,636 | 2,077 | 2,202 | 2,397 |
| Intangibles | 163,360 | 50,414 | 52,660 | 55,326 | 57,846 |
| Other Non-Current Assets | 52,878 | 29,076 | 32,388 | 17,577 | 14,516 |
| TOTAL | $217,406 | $81,126 | $87,125 | $75,105 | $74,759 |
| Total Assets | $406,160 | $253,732 | $253,190 | $254,554 | $238,603 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6,250 | 25,607 | 8,000 | 5,000 | 6,250 |
| Accounts payable and accrued liabilities | 18,993 | 16,431 | 6,268 | 5,462 | 9,917 |
| Accrued Expenses | 85,844 | 32,338 | 23,817 | N/A | 23,519 |
| Other current liabilities | N/A | N/A | N/A | 28,361 | N/A |
| TOTAL | $111,087 | $74,376 | $38,085 | $38,823 | $39,686 |
| Non-Current Liabilities | |||||
| Long Term Debt | 56,216 | N/A | 25,135 | 33,557 | 38,155 |
| Other Non-Current Liabilities | 5,297 | 2,903 | 3,959 | 3,000 | 0 |
| TOTAL | $61,513 | $2,903 | $29,094 | $36,557 | $38,155 |
| Total Liabilities | $172,600 | $77,279 | $67,179 | $75,380 | $77,841 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13,084 | 12,697 | 13,217 | 13,679 | 13,924 |
| Common Shares | 18 | 17 | 17 | 17 | 17 |
| Retained earnings | 111,504 | 75,862 | 84,489 | 72,500 | 58,187 |
| Other shareholders' equity | -1,227 | -205 | 102 | 139 | 100 |
| TOTAL | $233,560 | $176,453 | $186,011 | $179,174 | $160,762 |
| Total Liabilities And Equity | $406,160 | $253,732 | $253,190 | $254,554 | $238,603 |